For patients with relapsed or refractory multiple myeloma, Pomalidomide remains one of the most widely used treatment options after earlier therapies stop working.
Patients and their families often ask:
How much does Pomalidomide cost, and why are prices so different around the world?
The answer depends on the country, insurance coverage, and whether generic versions are available. In some healthcare systems, treatment may be covered by insurance or public healthcare. In others, patients may face significant out-of-pocket expenses.
Quick Overview: Pomalidomide Availability and Cost Considerations
